PrediSpot Test

Preventive Health Screening

PrediSpot Pictogram

Overview

The PrediSpot test analyses an individual’s DNA to identify inherited genetic traits associated with an increased risk of developing serious medical conditions such as Alzheimer’s disease, coronary artery disease, and sudden cardiac death.

Using a highly sensitive molecular biology technique known as quantitative polymerase chain reaction (qPCR), our scientists examine DNA extracted from a blood sample to detect specific genetic variations called single nucleotide polymorphisms (SNPs). These SNPs are linked to a higher likelihood of developing chronic and life-threatening diseases.

The PrediSpot test provides valuable insights that can help individuals and clinicians make better-informed decisions about future health, prevention, and lifestyle choices.

The test is clinically validated and highly accurate. It is suitable for adults aged 18 and over, and results are processed and returned within 14 business days.

Purpose of The Test

The PrediSpot test is designed to identify whether a person carries genetic variations that increase their risk of developing certain diseases.
It can reveal predispositions to a range of conditions, including:

  • Alzheimer’s disease
  • Coronary artery disease
  • Heart attack and sudden cardiac death
  • Hypertension
  • Type 1 and Type 2 diabetes
  • Osteoporosis
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Crohn’s disease
  • Systemic lupus erythematosus
  • Thrombosis
  • Asthma
  • Sjögren’s syndrome
  • Charcot-Marie-Tooth disease

By identifying these inherited risk factors, the PrediSpot test allows for proactive health management, early intervention, and better long-term planning.

Alzheimer’s pictogram

Alzheimer’s

Asthma pictogram

Asthma

Charcot-Marie-Tooth pictogram

Charcot-Marie-Tooth

Coronary Artery pictogram

Coronary Artery

Crohn’s Disease pictogram

Crohn’s Disease

Heart Attack and Sudden Cardiac Death  pictogram

Heart Attack and Sudden Cardiac Death 

Hypertension pictogram

Hypertension

Multiple Sclerosis pictogram

Multiple Sclerosis

Osteoporosis pictogram

Osteoporosis

Rheumatoid Arthritis pictogram

Rheumatoid Arthritis

Sjögren’s syndrome pictogram

Sjögren’s syndrome

Systemic lupus Erythematosus pictogram

Systemic lupus Erythematosus

Thrombosis  pictogram

Thrombosis 

Type 1 and Type 2 diabetes pictogram

Type 1 and Type 2 diabetes

Scientific Background

The PrediSpot test relies on quantitative polymerase chain reaction (qPCR) — an advanced molecular technique that amplifies and measures DNA sequences in real time.

DNA is extracted from a blood sample and used as a template in the qPCR process.
During testing, specific TaqMan probes target and detect single nucleotide polymorphisms (SNPs) associated with a range of hereditary diseases.

To ensure accuracy and reproducibility, all reactions are performed in triplicate, and both positive and negative controls are run for each genetic marker.
This rigorous process ensures the highest level of reliability in detecting genetic variants linked to disease susceptibility.

When to Consider the Test

The PrediSpot test may be considered if you:

  • Have a family history of serious medical conditions such as heart disease, Alzheimer’s, or autoimmune disorders.
  • Wish to take a proactive approach to managing your long-term health.
  • Are considering personalised lifestyle or preventive strategies based on your genetic profile.
  • Want to better understand genetic risk factors that could influence future medical decisions or screening.

The test is suitable for preventive health planning, even in the absence of symptoms.

Samples & Processing

Once the test is ordered, you will receive a sample collection kit in the mail or via an approved medical clinician which includes:

  • Step-by-step instructions for collecting a blood sample
  • Secure packaging to protect your sample in transit
  • A pre-labeled return envelope for sending it back to our laboratory

Once received, your sample is processed under strict internal quality controls.
Results are typically available within 14 business days from the date the sample arrives at our facility. All analyses are performed using validated molecular and biochemical techniques in Biocentaur’s certified laboratories, ensuring the highest standards of accuracy and reproducibility.

Result Interpretation

Your report includes detailed information about each gene tested, whether specific SNPs were detected, and what those findings may indicate regarding disease risk.

Results should be reviewed in the context of other health information, lifestyle, and family history.
While a positive result indicates a predisposition, it does not mean you will definitely develop the condition — rather, it helps guide preventive action and targeted health monitoring. A negative result does not mean you will not develop conditions in the future and it’s important to keep monitoring your health through regular testing.

If you wish, our clinical support team can connect you with a Biocentaur approved clinician  for follow-up guidance.

Why Choose PrediSpot Test

The PrediSpot test is developed by the same team of scientists behind RGCC International’s clinically validated cancer diagnostics.

Our expertise in precision medicine, molecular biology, and genetic analysis ensures reliable results and cutting-edge scientific accuracy.
We bring the same clinical rigour and commitment to quality that underpin our oncology research to every PrediSpot test — empowering individuals to take control of their genetic health with confidence.

Good to know: The PrediSpot test can be ordered directly by individuals — no medical clinician referral is required. DNA can be extracted from a blood sample. However, if you would like guidance interpreting your results, contact us via our contact form and our clinical team can connect you with a Biocentaur approved medical clinician.